We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

Microwave Radiation Can Kill Breast Cancer Cells

By HospiMedica staff writers
Posted on 03 Jan 2001
In a phase I clinical trial, researchers found that one to three weeks following a single treatment by a new microwave radiation system, advanced breast cancer tumors typically were reduced in size or destroyed by about 50% in eight out of 10 patients. More...
Phase II clinical trials will now be conducted.

In the procedure, two needle probes are used to sense and measure parameters during treatment. The focused microwave radiation does not heat the skin but heats the cancer cells to about 1150 F and kills them. Breast cancer cells have a high water content, around 80%, while healthy breast tissue contains only 20-60%. The new system has the potential to reduce or eliminate the use of conventional radiation. In the phase II trials, more than 100 women will receive microwave thermotherapy to treat cancer cells. The microwave technology has been licensed to Celsion Corp. (Columbia, MD, USA) by the Massachusetts Institute of Technology (Cambridge, MA, USA).

The new technique was invented by Alan J. Fenn, a senior staff member of MIT's Air Defense Technology Division, based on research he had conducted on radar anti-jamming technology to detect missiles from space-borne satellites. "This is an out-patient procedure,” said Dr. Fenn. "Patients treated in the phase I trial went home with only one or two tiny band aids.”



Related Links:
Celsion

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Elyra TFL System uses thulium fiber laser technology for efficient stone dusting and reduced stone migration, with an air-cooled design for quieter, more compact operation (photo courtesy of BD

BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures

BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.